Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1565
-
Total 13F shares, excl. options
-
204M
-
Shares change
-
+4.03M
-
Total reported value, excl. options
-
$79.3B
-
Value change
-
+$1.42B
-
Put/Call ratio
-
0.71
-
Number of buys
-
712
-
Number of sells
-
-789
-
Price
-
$388.96
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2025
1,831 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2025.
Elevance Health, Inc. - Common Stock (ELV) has 1,565 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 204M shares
of 226M outstanding shares and own 90.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (22.9M shares), BlackRock, Inc. (20.4M shares), STATE STREET CORP (10.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.09M shares), Capital International Investors (6.49M shares), WELLINGTON MANAGEMENT GROUP LLP (6.32M shares), Sanders Capital, LLC (5.83M shares), GEODE CAPITAL MANAGEMENT, LLC (5.09M shares), Artisan Partners Limited Partnership (3.68M shares), and First Eagle Investment Management, LLC (3.2M shares).
This table shows the top 1565 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.